Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-04-24Clinical Trial Update: Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial evaluating induction gemcitabine and cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma [Phase 1]
This Phase 1 trial update evaluated concurrent chemoradiotherapy with famitinib in patients with locally advanced nasopharyngeal carcinoma; …
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma [Phase 1, Phase 2]
A safety and efficacy study evaluating icotinib in combination with intensity-modulated radiotherapy for nasopharyngeal carcinoma (Phase 1/P…
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: Dose Escalation of Lobaplatin Concurrent With IMRT for the Treatment of NPC: A Phase I Clinical Trial [Phase 1]
Phase I dose-escalation study of lobaplatin given concurrently with IMRT for nasopharyngeal carcinoma, evaluating safety and preliminary tum…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Capecitabine For Nasopharyngeal Cancer [Phase 2]
Phase 2 clinical trial of capecitabine for nasopharyngeal carcinoma has completed, with Dana-Farber Cancer Institute listed as sponsor.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients [Phase 2]
A Phase 2 clinical trial tested whether oral supplements improve nutritional status in locally advanced nasopharyngeal carcinoma patients; t…
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating induction cisplatin and capecitabine followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma has compl…
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating early and whole-course nutritional support with Nutren Optimum during IMRT for nasopharyngeal carcinom…
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC [Phase 2]
Phase II trial evaluating chemotherapy with or without Endostar continuous IV infusion in refractory nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis [Phase 2]
A Phase 2 trial evaluating atorvastatin to prevent carotid stenosis in nasopharyngeal carcinoma patients receiving radiotherapy has been sus…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy [NA]
A clinical trial update comparing oxycodone to control for chemoradiotherapy-induced oral mucositis pain in nasopharyngeal carcinoma.
-
CLINICAL_TRIALS research · 2017-11-07Clinical Trial Update: The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients
This clinical trial update examines whether anxiety and depression affect survival in patients with nasopharyngeal carcinoma. The current st…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients [Phase 2]
A Phase 2 clinical trial update reports that aspirin may improve survival in patients with advanced nasopharyngeal carcinoma (N2-3).
-
CLINICAL_TRIALS trial_result · 2017-10-20Clinical Trial Update: Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA
This completed clinical trial reports long-term treatment outcomes for stage III nasopharyngeal carcinoma patients and evaluates risk groupi…
-
CLINICAL_TRIALS trial_result · 2017-10-20Clinical Trial Update: NBI to Detect Post-RT Mucosal Residual NPC [NA]
The trial evaluated using narrow-band imaging (NBI) to detect residual mucosal disease after radiotherapy in nasopharyngeal carcinoma, with …
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes [Phase 2]
Phase 2 study evaluating carboplatin and docetaxel followed by Epstein-Barr virus–specific cytotoxic T lymphocytes in nasopharyngeal carcino…
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC) [Phase 2]
A Phase 2 clinical trial evaluating induction chemotherapy with docetaxel, cisplatin, and fluorouracil with intensity-modulated radiotherapy…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) [Phase 2]
A Phase 2 trial update is reported for apatinib in treating recurrent or metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC. [Phase 2]
Phase 2 clinical trial evaluating the combination of lobaplatin and 5-fluorouracil for recurrent nasopharyngeal carcinoma; current study sta…
-
CLINICAL_TRIALS research · 2017-06-28Clinical Trial Update: Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Carcinoma
This clinical trial update investigates predictive factors for the development of acute oral mucositis in patients with locally advanced nas…
-
CLINICAL_TRIALS research · 2017-06-23Clinical Trial Update: the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer [Phase 2]
Phase 2 study evaluating chronomodulated chemotherapy's effect on dendritic cell subsets in advanced nasopharyngeal carcinoma. The trial is …
-
CLINICAL_TRIALS research · 2017-06-15Clinical Trial Update: Phase IIa Dose-Expansion and Biomarker Study of OPB-111077 [Phase 2]
Phase IIa dose-expansion and biomarker study of OPB-111077 for nasopharyngeal carcinoma and refractory tumors, with current status unspecifi…
-
CLINICAL_TRIALS research · 2017-06-15Clinical Trial Update: A Study of Nasopharyngeal Carcinoma From Guangdong
A Sun Yat-sen University clinical trial from Guangdong studying nasopharyngeal carcinoma; the trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial update reports on eliminating adjuvant chemotherapy for selected stage II and III nasopharyngeal carcinoma.
-
CLINICAL_TRIALS research · 2017-05-02Clinical Trial Update: PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating PD-1 knockout EBV-specific cytotoxic T lymphocytes for advanced EBV-associated malignancies, includ…